DE3685818D1 - - Google Patents

Info

Publication number
DE3685818D1
DE3685818D1 DE86301682T DE3685818T DE3685818D1 DE 3685818 D1 DE3685818 D1 DE 3685818D1 DE 86301682 T DE86301682 T DE 86301682T DE 3685818 T DE3685818 T DE 3685818T DE 3685818 D1 DE3685818 D1 DE 3685818D1
Authority
DE
Germany
Prior art keywords
associated antigen
tumor associated
immune complexes
serum
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE86301682T
Other languages
English (en)
Other versions
DE3685818T2 (de
Inventor
Anil K. Edmonds Washington 98020 Us Singhal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IMRE CORP SEATTLE WASH US
Original Assignee
IMRE CORP SEATTLE WASH US
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IMRE CORP SEATTLE WASH US filed Critical IMRE CORP SEATTLE WASH US
Publication of DE3685818D1 publication Critical patent/DE3685818D1/de
Application granted granted Critical
Publication of DE3685818T2 publication Critical patent/DE3685818T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE8686301682T 1986-03-10 1986-03-10 Immunkomplextestverfahren. Expired - Fee Related DE3685818T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP86301682A EP0236606B1 (de) 1986-03-10 1986-03-10 Immunkomplextestverfahren

Publications (2)

Publication Number Publication Date
DE3685818D1 true DE3685818D1 (de) 1992-07-30
DE3685818T2 DE3685818T2 (de) 1993-01-14

Family

ID=8195922

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686301682T Expired - Fee Related DE3685818T2 (de) 1986-03-10 1986-03-10 Immunkomplextestverfahren.

Country Status (4)

Country Link
EP (1) EP0236606B1 (de)
JP (1) JPS62231172A (de)
AT (1) ATE77700T1 (de)
DE (1) DE3685818T2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1326814C (en) * 1987-08-11 1994-02-08 Eiji Ishikawa Method of high sensitivity immunoassay
US5236849A (en) * 1987-08-11 1993-08-17 Eiji Ishikawa Method of high sensitivity immunoassay
JP2606722B2 (ja) * 1988-04-05 1997-05-07 栄治 石川 超高感度抗原物質の測定法
JP2657672B2 (ja) * 1987-08-11 1997-09-24 栄治 石川 超高感度特異的抗体の測定法
US5236830A (en) * 1988-11-10 1993-08-17 Eiji Ishikawa Method of assay for antigen
GB9810040D0 (en) 1998-05-11 1998-07-08 Univ Nottingham Blood borne tumour markers
GB9827228D0 (en) 1998-12-10 1999-02-03 Univ Nottingham Cancer detection method and reagents
AT409801B (de) * 2000-05-31 2002-11-25 Cistem Biotechnologies Gmbh Verfahren zum screenen und isolieren von mikroorganismen, insbesondere prokaryontischer und eukaryontischer zellen, die ein antigen präsentieren
GB2395270B (en) 2002-11-14 2006-08-16 Univ Nottingham Tumour marker proteins and uses thereof
GB2426581A (en) 2005-05-27 2006-11-29 Univ Nottingham Immunoassay methods
RU2636532C2 (ru) 2005-05-27 2017-11-23 Онкиммьюн Лимитед Улучшенные способы иммуноанализа
US8574848B2 (en) 2006-09-13 2013-11-05 Oncimmune Ltd. Immunoassay methods
CN112379093B (zh) * 2020-10-22 2023-06-16 上海良润生物医药科技有限公司 CST-Cathepsin复合物作为肿瘤诊断标志物的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1508133A (en) * 1975-05-20 1978-04-19 Technicon Instr Biological analysis
DE2836046A1 (de) * 1978-08-17 1980-02-28 Behringwerke Ag Immunologisches bestimmungsverfahren
JPS5915858A (ja) * 1982-07-16 1984-01-26 Otsuka Pharmaceut Co Ltd 腫瘍関連抗原特異的免疫複合体の測定法
JPS60192263A (ja) * 1984-03-13 1985-09-30 Teijin Ltd 免疫複合体測定用標準物質及びそれを用いた免疫複合体の測定法

Also Published As

Publication number Publication date
JPS62231172A (ja) 1987-10-09
ATE77700T1 (de) 1992-07-15
EP0236606B1 (de) 1992-06-24
EP0236606A1 (de) 1987-09-16
DE3685818T2 (de) 1993-01-14

Similar Documents

Publication Publication Date Title
ZA891568B (en) Method for determination of a polyvalent substance using an immunoaggregate
DE3685818D1 (de)
EP0212489A3 (en) Anabolic activity modulator and uses thereof
EP0161306A4 (de) Verfahren zum nachweis von immunkomplexen im serum.
JPS57200862A (en) Mutilayer analysis element utilizing unique binding reaction
ZA878508B (en) Novel immunochemical method for assaying stable glycosylated hemoglobin
DE3485265D1 (de) Verfahren zur bestimmung eines polyvalenten antigens und reagenz hierfuer.
FR2563630B1 (fr) Anticorps monoclonaux anticytomegalovirus et procedes pour le diagnostic in vitro des infections par les cytomegalovirus humains et d'une proteine-kinase inductible par les cytomegalovirus et susceptible d'etre reconnue par les susdits anticorps monoclonaux
ES8701990A1 (es) Procedimiento para la determinacion de la capacidad de fijacion de la globulina fijadora de tiroxina
ZA875825B (en) Determination of analyte concentration using two labelling markers
IL78148A0 (en) Assay for antigens and antibodies and methods and device for carrying out thereof
DE3790139D2 (en) Antiparatypical antibodies, their use for detecting and treating auto-immune diseases
DE3273844D1 (en) Procedure for immunological determinations using two antibodies, the second antibody being purified by affinity chromatography, and supports therefor
DE58909219D1 (de) Einschritt-Immuntest zur Bestimmung von antigen-spezifischen Antikörpern aller Immunglobulin-Klassen und dazu geeignetes Mittel.
EP0233061A3 (en) Reagent for detecting antibody to viral antigen
CS555888A1 (en) Method of pure specific antibodies production for proteins concentration's quick quantitative determination
FR2608925B1 (fr) Composition de polypeptides a action immunologique, son procede de preparation, et son utilisation pour la preparation de vaccins antipaludeens et de trousses de diagnostic pour la detection d'anticorps antimerozoaires
PT83106A (en) Method for determining the presence of specific igg in human serum
AU2713288A (en) Human-type serum obtained from fractions resulting from the fractionation of human blood or serum, process for its preparation and laboratory reaction containing said serum
IT8606606A0 (it) Test immunoenzimatico per la ricerca anticorpi anti-insulina nel siero
IL78445A0 (en) Antibodies to(2'-5')oligo-a-synthetase,an interferon induced enzyme,and an assay for said enzyme and its different subtypes,applying said antibodies
IE842182L (en) Assay kit for detection of antibodies in human serum
IE860311L (en) Reagent for determination of antibodies
IE881731L (en) Method for separating labelled reagent in an immunometric¹binding assay
IE882302L (en) Antigen fractions for detecting antibodies indicative of a¹cardiovascular risk

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee